Unnamed: 0,title,date,stock,sentiment
801651.0,Masimo And Philips Announce Licensing Agreement,2020-05-27 08:12:00-04:00,MASI,positive
801652.0,"The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter",2020-05-13 07:40:00-04:00,MASI,neutral
801653.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-12 10:41:00-04:00,MASI,neutral
801654.0,"The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings",2020-05-12 08:06:00-04:00,MASI,negative
801655.0,'Jim Cramer reviews top 10 stocks 'for this difficult moment' on the 'Cramer Covid-19 Index'' -CNBC,2020-05-11 21:48:00-04:00,MASI,negative
801656.0,Stocks That Hit 52-Week Highs On Monday,2020-05-11 10:28:00-04:00,MASI,neutral
801657.0,"The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda",2020-05-08 07:59:00-04:00,MASI,neutral
801658.0,Stocks That Hit 52-Week Highs On Thursday,2020-05-07 10:33:00-04:00,MASI,neutral
801659.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,MASI,negative
801661.0,"The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle",2020-05-06 08:42:00-04:00,MASI,positive
801662.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-05 10:48:00-04:00,MASI,neutral
801663.0,"The Daily Biotech Pulse: Bio-Rad's Coronavirus Test Gets EUA, Beat-And-Raise Quarter From GenMark, Adverum's Positive Gene Therapy Readout",2020-05-05 08:00:00-04:00,MASI,positive
801664.0,"Study Finds Noninvasive, Continuous Masimo PVi Monitoring More Valuable Than Central Venous Pressure Measurement for Guiding Fluid Management During Surgery",2020-05-04 05:25:00-04:00,MASI,positive
801665.0,"UBS Maintains Buy on Masimo, Raises Price Target to $245",2020-04-30 09:40:00-04:00,MASI,neutral
801666.0,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1",2020-04-30 07:19:00-04:00,MASI,positive
801667.0,"Stifel Maintains Buy on Masimo, Raises Price Target to $245",2020-04-29 10:24:00-04:00,MASI,neutral
801668.0,Stocks That Hit 52-Week Highs On Wednesday,2020-04-29 10:16:00-04:00,MASI,neutral
801669.0,"The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda",2020-04-29 08:40:00-04:00,MASI,positive
801670.0,From Masimo Earnings Conference Call: Withdraws FY20 Guidance,2020-04-28 17:07:00-04:00,MASI,neutral
801671.0,"Masimo Q1 Adj. EPS $0.970, Inline",2020-04-28 17:06:00-04:00,MASI,neutral
801672.0,"Masimo Q1 EPS $1.120 Up From $0.870 YoY, Sales $269.600M Beat $257.770M Estimate",2020-04-28 16:20:00-04:00,MASI,neutral
801673.0,"The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update",2020-04-28 07:36:00-04:00,MASI,neutral
801674.0,Stocks That Hit 52-Week Highs On Monday,2020-04-27 10:21:00-04:00,MASI,neutral
801675.0,"The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight",2020-04-26 16:37:00-04:00,MASI,negative
801676.0,Stocks That Hit 52-Week Highs On Friday,2020-04-24 10:33:00-04:00,MASI,neutral
801677.0,"Benzinga's Top Upgrades, Downgrades For April 20, 2020",2020-04-20 09:32:00-04:00,MASI,positive
801678.0,Masimo shares are trading lower after Needham downgraded the company's stock from Buy to Hold.,2020-04-20 07:10:00-04:00,MASI,neutral
801679.0,Needham Downgrades Masimo to Hold,2020-04-20 06:02:00-04:00,MASI,neutral
801680.0,Stocks That Hit 52-Week Highs On Friday,2020-04-17 10:19:00-04:00,MASI,neutral
801681.0,"The Daily Biotech Pulse: Moderna Secures $483M In BARDA Funding, Gilead Remdesivir Data, Veracyte's Positive Pre-Announcement",2020-04-17 07:35:00-04:00,MASI,positive
801682.0,10 Stocks Hitting All-Time Highs Amid The COVID-19 Pandemic,2020-04-16 17:21:00-04:00,MASI,neutral
801683.0,Stocks That Hit 52-Week Highs On Thursday,2020-04-16 10:19:00-04:00,MASI,neutral
801684.0,"The Daily Biotech Pulse: FDA Nod For UroGen, Novavax Coronavirus Vaccine To Enter Clinics, Soligenix Licenses Vaccine Adjuvant",2020-04-16 08:09:00-04:00,MASI,neutral
801685.0,Stocks That Hit 52-Week Highs On Wednesday,2020-04-15 10:48:00-04:00,MASI,neutral
801686.0,"The Daily Biotech Pulse: Applied DNA Ships Vaccine Constructs For Animal Testing, Herceptin Biosimilar Now Available In US",2020-04-15 08:03:00-04:00,MASI,neutral
801687.0,"The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO",2020-04-08 07:53:00-04:00,MASI,neutral
801688.0,"The Daily Biotech Pulse: Sanofi, Regeneron Finalize Praluent Restructuring, Natus Pre-Announces Q1 Shortfall, Alcon To Delay Dividend Initiation",2020-04-07 07:55:00-04:00,MASI,negative
801689.0,Shares of several healthcare companies are trading lower amid market volatility. Sunday's fiscal stimulus bill failed a procedural senate vote while the Fed Monday morning announced further stimulus measures to support liquidity.,2020-03-23 11:31:00-04:00,MASI,negative
801690.0,Masimo Reports Will Make Rainbow Licenses Available For No Added Charge To Hospitals Where Devices Already In Use,2020-03-23 08:13:00-04:00,MASI,negative
801691.0,"The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company",2020-03-20 07:44:00-04:00,MASI,negative
801692.0,"Masimo Reports Joint Announcement With University Hospitals Of Its Telehealth Solution, Masimo SafetyNet",2020-03-20 06:01:00-04:00,MASI,positive
801693.0,"Masimo Reports Purchase Of TNI medical, No Terms Disclosed",2020-03-19 16:01:00-04:00,MASI,negative
801694.0,"Shares of several healthcare companies are trading lower as the coronavirus outbreak continues to cause economic disruption around the globe, leading to a steep selloff in equities across sectors.",2020-03-16 10:50:00-04:00,MASI,negative
801695.0,"Benzinga's Top Upgrades, Downgrades For March 2, 2020",2020-03-02 09:40:00-05:00,MASI,positive
801696.0,Masimo Announces FDA Clearance of its Continuous RRp Monitoring,2020-03-02 08:11:00-05:00,MASI,neutral
801697.0,"Raymond James Upgrades Masimo to Outperform, Announces $183 Price Target",2020-03-02 07:02:00-05:00,MASI,neutral
801698.0,"Masimo Reports Expansion Of Partnership With MS Westfalia To Add Co.'s SedLine Brain Function Monitoring, O3 Regional Oximetry, Oxygen Reserve Index To MSW Modular Point Of Care Hybrid Jenny",2020-02-25 08:06:00-05:00,MASI,positive
801699.0,"The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion",2020-02-21 07:46:00-05:00,MASI,negative
801700.0,Stocks That Hit 52-Week Highs On Thursday,2020-02-20 10:26:00-05:00,MASI,neutral
801701.0,"UBS Maintains Buy on Masimo, Raises Price Target to $207",2020-02-20 07:58:00-05:00,MASI,neutral
801702.0,"Needham Maintains Buy on Masimo, Raises Price Target to $201",2020-02-20 06:39:00-05:00,MASI,neutral
801703.0,Masimo shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.,2020-02-19 16:31:00-05:00,MASI,positive
801704.0,"Masimo Sees FY20 Adj. EPS $3.56 vs $3.55 Est., Sales $1.035B vs $1.03B Est.",2020-02-19 16:16:00-05:00,MASI,neutral
801705.0,"Masimo Q4 Adj. EPS $0.91 Beats $0.87 Estimate, Sales $247.5M Beat $243.79M Estimate",2020-02-19 16:14:00-05:00,MASI,neutral
801706.0,"The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA",2020-02-19 07:21:00-05:00,MASI,negative
801707.0,"The Week Ahead In Biotech: Baudax Bio, Merck, Esperion Await FDA Decisions",2020-02-16 15:03:00-05:00,MASI,positive
801708.0,Stocks That Hit 52-Week Highs On Friday,2020-02-14 10:15:00-05:00,MASI,neutral
801709.0,"The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering",2020-02-14 08:23:00-05:00,MASI,negative
801710.0,"The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO",2020-02-13 08:05:00-05:00,MASI,negative
801711.0,Stocks That Hit 52-Week Highs On Wednesday,2020-02-12 11:45:00-05:00,MASI,neutral
801712.0,"The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data",2020-02-12 09:18:00-05:00,MASI,positive
801713.0,Stocks That Hit 52-Week Highs On Tuesday,2020-02-11 10:17:00-05:00,MASI,neutral
801714.0,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",2020-02-11 07:23:00-05:00,MASI,positive
801715.0,"The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs",2020-02-06 07:47:00-05:00,MASI,negative
801716.0,Stocks That Hit 52-Week Highs On Wednesday,2020-02-05 10:16:00-05:00,MASI,neutral
801717.0,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data",2020-02-05 07:43:00-05:00,MASI,neutral
801718.0,Stocks That Hit 52-Week Highs On Tuesday,2020-02-04 10:18:00-05:00,MASI,neutral
801719.0,"The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment",2020-01-23 07:24:00-05:00,MASI,positive
801720.0,Stocks That Hit 52-Week Highs On Wednesday,2020-01-22 10:17:00-05:00,MASI,neutral
801721.0,"The Daily Biotech Pulse: Johnson & Johnson Earnings, FDA Nod For Horizon Therapeutics, Slew Of Secondary Offerings",2020-01-22 08:25:00-05:00,MASI,neutral
801722.0,Stocks That Hit 52-Week Highs On Friday,2020-01-17 13:23:00-05:00,MASI,neutral
801723.0,"The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares",2020-01-17 08:07:00-05:00,MASI,negative
801724.0,Stocks That Hit 52-Week Highs On Thursday,2020-01-16 10:22:00-05:00,MASI,neutral
801725.0,"The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics",2020-01-16 07:22:00-05:00,MASI,neutral
801726.0,Stocks That Hit 52-Week Highs On Wednesday,2020-01-15 13:14:00-05:00,MASI,neutral
801727.0,"UBS Maintains Buy on Masimo, Raises Price Target to $190",2020-01-15 08:57:00-05:00,MASI,neutral
801728.0,"Masimo Sees Prelim. FY19 Sales $934M-$937M; Sees FY20 Adj. EPS $3.56 vs $3.56 Est., Sales $1.035B vs $1.04B Est.",2020-01-14 09:06:00-05:00,MASI,neutral
801729.0,Masimo To Acquire Connected Care Business From NantHealth For $47.25M In Cash,2020-01-14 09:01:00-05:00,MASI,positive
801730.0,"The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug",2020-01-14 07:55:00-05:00,MASI,positive
801731.0,Stocks That Hit 52-Week Highs On Friday,2020-01-10 12:18:00-05:00,MASI,neutral
801732.0,"The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx",2020-01-10 07:13:00-05:00,MASI,positive
801733.0,Stocks That Hit 52-Week Highs On Thursday,2020-01-09 15:15:00-05:00,MASI,neutral
801734.0,Masimo Announces FDA Clearance For Neonatal RD SET Pulse Oximetry Sensors With Improved Accuracy Specifications,2019-12-30 08:07:00-05:00,MASI,positive
801735.0,Masimo Announces CE Mark for Radius Capnography for the Root Patient Monitoring and Connectivity Platform,2019-10-31 04:07:00-04:00,MASI,neutral
801736.0,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",2019-10-30 07:01:00-04:00,MASI,negative
801737.0,Masimo Highlights Study Investigating Effects Of Co.'s SpHb Hemoglobin Monitoring on Postoperative Anemia and Inappropriate Blood Transfusion in Patients Undergoing Hip and Knee Surgery,2019-10-23 17:05:00-04:00,MASI,neutral
801738.0,Study Investigates the Utility of Masimo ORi to Reduce Hyperoxia in Critically Ill Patients,2019-08-26 03:47:00-04:00,MASI,negative
801739.0,"The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission",2019-08-16 07:33:00-04:00,MASI,negative
801740.0,Masimo Announces Investment In Pulmonary Care Company TNI Medical AG,2019-08-15 17:00:00-04:00,MASI,positive
801741.0,"Masimo Announces Study Published in Journal of Clinical Monitoring and Computing Demonstrates Reduction in Mortality Using Masimo Noninvasive, Continuous Hemoglobin (SpHb®) and Pleth Variability Index (PVi®) Monitoring",2019-08-07 04:16:00-04:00,MASI,neutral
801742.0,"Stifel Nicolaus Maintains Buy on Masimo, Raises Price Target to $170",2019-08-01 08:45:00-04:00,MASI,neutral
801743.0,"UBS Maintains Buy on Masimo, Raises Price Target to $180",2019-08-01 08:43:00-04:00,MASI,neutral
801744.0,"Masimo Q2 EPS $0.79 Beats $0.73 Estimate, Sales $229.7M Beat $222.46M Estimate",2019-07-31 16:56:00-04:00,MASI,neutral
801745.0,Companies That Achieved 52-Week Highs Friday,2019-07-26 15:37:00-04:00,MASI,neutral
801746.0,"The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug",2019-07-25 07:21:00-04:00,MASI,negative
801747.0,Masimo Announces New Study Investigates Utility of Oxygen Reserve Index as an Indicator to Avoid Hyperoxia During General Anesthesia,2019-07-15 03:28:00-04:00,MASI,negative
801748.0,"The Daily Biotech Pulse: Hookipa Leaps, Illumina Dims On Q2 Warning, Novartis-Amgen Halt Alzheimer's Study",2019-07-12 07:24:00-04:00,MASI,negative
801749.0,Masimo Reports FDA Clearance Of Neonatal Indication For O3 Regional Oximetry,2019-06-10 08:05:00-04:00,MASI,neutral
801750.0,Shares of many healthcare companies are trading lower following a tweet from President Trump late Thursday stating the US will impose a 5 percent tariff on goods from Mexico.,2019-05-31 10:25:00-04:00,MASI,negative
801751.0,Masimo Announces New Study Evaluates Ability of SpHb to Estimate Timing for Invasive Measurement to Detect Anemia During Surgery,2019-05-20 03:37:00-04:00,MASI,positive
801752.0,"The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering",2019-05-17 08:03:00-04:00,MASI,neutral
801753.0,Masimo Reports FDA Clearance Of Radius PPG,2019-05-16 08:09:00-04:00,MASI,neutral
801754.0,"Masimo, Mindray Expand Partnership",2019-05-13 04:12:00-04:00,MASI,positive
801755.0,"UBS Maintains Buy on Masimo Corporation - Common Stock, Raises Price Target to $160",2019-05-07 09:14:00-04:00,MASI,neutral
801756.0,Masimo Sees FY19 Adj. EPS $3.12 vs $3.08 Est.,2019-05-06 16:48:00-04:00,MASI,neutral
801757.0,Masimo Raises FY19 Sales Guidance From $912M-$918M vs $912.74M Est.,2019-05-06 16:48:00-04:00,MASI,neutral
801758.0,"Masimo Q1 Adj. EPS $0.79 Beats $0.75 Estimate, Sales $231.664M Beat $223.7M Estimate",2019-05-06 16:47:00-04:00,MASI,neutral
801759.0,"Earnings Scheduled For May 6, 2019",2019-05-06 04:39:00-04:00,MASI,neutral
801760.0,Masimo Announces First CE-marked Third-party Masimo Open Connect Module for the Root Patient Monitoring and Connectivity Hub,2019-04-29 03:44:00-04:00,MASI,neutral
801761.0,Shares of several medical device companies are trading lower with the healthcare sector. Healthcare has seen weakness recently due to concerns over the future of the Affordable Act under Trump and healthcare policy uncertainty ahead of the 2020 election.,2019-04-17 12:45:00-04:00,MASI,negative
801762.0,"Benzinga's Top Upgrades, Downgrades For April 16, 2019",2019-04-16 08:54:00-04:00,MASI,positive
801763.0,BTIG Research Downgrades Masimo to Neutral,2019-04-16 07:41:00-04:00,MASI,neutral
801764.0,Masimo Announces ew Study Investigates Cerebral Oxygenation Normative Values Using O3 Regional Oximetry,2019-04-15 03:51:00-04:00,MASI,positive
801765.0,"The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial",2019-04-02 07:30:00-04:00,MASI,neutral
801766.0,Masimo Announces FDA Clearance of the Rad-67 Pulse CO-Oximeter,2019-03-25 08:09:00-04:00,MASI,neutral
801767.0,"The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback",2019-03-22 08:16:00-04:00,MASI,negative
801768.0,"Masimo Reports St. Luke's University Health Network Will Expand Use Of Variety Of Co. Technologies, No Terms Disclosed",2019-03-19 17:01:00-04:00,MASI,neutral
801769.0,Masimo Announces CE Mark for Pediatric Indication for Next Generation SedLine Brain Function Monitoring,2019-03-04 03:57:00-05:00,MASI,neutral
801770.0,"The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems",2019-02-28 08:24:00-05:00,MASI,positive
801771.0,Masimo Sees FY19 Sales $912M vs $909.6M Estimate,2019-02-26 17:04:00-05:00,MASI,neutral
801772.0,"Masimo Q4 EPS $0.83 Beats $0.73 Estimate, Sales $223.1M Beat $219.96M Estimate",2019-02-26 17:03:00-05:00,MASI,neutral
801773.0,"The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote",2019-02-26 07:56:00-05:00,MASI,positive
801774.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",2019-02-22 13:55:00-05:00,MASI,neutral
801775.0,"The Daily Biotech Pulse: Exelixis Q4 Results, FDA Panel Greenlights J&J's Depression Drug, MacroGenics Prices Offering",2019-02-13 07:49:00-05:00,MASI,negative
801776.0,Masimo Reports FDA Clearance Of RRp On MightySat Rx Spot-Check Fingertip Pulse Oximeter,2019-01-28 08:00:00-05:00,MASI,neutral
801777.0,Masimo shares are trading higher after the company issued strong FY19 guidance.,2019-01-09 14:22:00-05:00,MASI,positive
801778.0,Masimo Sees FY18 Total Sales $855M-$858M vs $854.2M Estimate; Sees FY19 Product Sales ~$910M,2019-01-09 08:33:00-05:00,MASI,neutral
801779.0,Masimo Sees FY19 Adj. EPS $3.05 vs $3.04 Estimate,2019-01-09 08:32:00-05:00,MASI,neutral
801780.0,Masimo Sees FY18 Adj. EPS $2.92 vs $2.93 Estimate,2019-01-09 08:32:00-05:00,MASI,neutral
801781.0,"Benzinga's Top Upgrades, Downgrades For December 19, 2018",2018-12-19 09:11:00-05:00,MASI,positive
801782.0,"PiperJaffray Upgrades Masimo to Overweight, Announces $120 Price Target",2018-12-19 07:33:00-05:00,MASI,negative
801783.0,"UBS Initiates Coverage On Masimo with Buy Rating, Announces $137 Price Target",2018-11-28 08:09:00-05:00,MASI,neutral
801784.0,Masimo Announces International Consensus Statement on Postoperative Anemia Management Recommends Noninvasive Hemoglobin Measurement Including Masimo SpHb,2018-11-12 03:39:00-05:00,MASI,positive
801785.0,Masimo Raises FY2018 EPS Guidance from $2.90 to $2.92 vs $2.91 Est; Raises FY2018 Sales Guidance from $850.0M to $854.0M vs $850.80M Est,2018-10-31 16:33:00-04:00,MASI,neutral
801786.0,"Masimo Corporation Q3 EPS $0.71 Beats $0.69 Estimate, Sales $210.583M Beat $207.62M Estimate",2018-10-31 16:32:00-04:00,MASI,neutral
801787.0,Masimo Announces FDA Clearance For Masimo RD Sensors With Improved Accuracy Specifications For SET Pulse Oximetry,2018-10-25 08:27:00-04:00,MASI,positive
801788.0,"Stocks Which Set New 52-Week High Yesterday, October 2nd",2018-10-03 12:59:00-04:00,MASI,neutral
801789.0,"The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares",2018-10-03 07:54:00-04:00,MASI,positive
801790.0,10 Biggest Price Target Changes For Tuesday,2018-10-02 09:48:00-04:00,MASI,neutral
801791.0,"Stocks Which Set New 52-Week High Yesterday, October 1st",2018-10-02 09:20:00-04:00,MASI,neutral
801792.0,"Stifel Nicolaus Maintains Buy on Masimo, Raises Price Target to $145",2018-10-02 07:14:00-04:00,MASI,neutral
801793.0,Masimo Announces New Study Evaluates the Ability of ORi to Help Clinicians Reduce Hyperoxemia in Mechanically Ventilated ICU Patients,2018-10-01 04:31:00-04:00,MASI,positive
801794.0,"Stocks Which Set New 52-Week High Yesterday, September 25th",2018-09-26 11:53:00-04:00,MASI,neutral
801795.0,"Stocks Which Set New 52-Week High Friday, September 14th",2018-09-17 09:28:00-04:00,MASI,neutral
801796.0,"Stocks Which Set New 52-Week High Yesterday, September 13th",2018-09-14 09:26:00-04:00,MASI,neutral
801797.0,"Needham Initiates Coverage On Masimo with Buy Rating, Announces $139 Price Target",2018-09-14 08:46:00-04:00,MASI,neutral
801798.0,"The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut",2018-09-14 08:38:00-04:00,MASI,neutral
801799.0,"Masimo Reports FDA Clearance For Its Rainbow Acoustic Monitoring RAS-45 Sensor For Infant, Neonatal Patients",2018-09-10 08:00:00-04:00,MASI,neutral
801800.0,"Stocks Which Set New 52-Week High Yesterday, September 4th",2018-09-05 10:22:00-04:00,MASI,neutral
801801.0,"The Daily Biotech Pulse: Biohaven In-Licenses Drug, Retrophin's Debt Offering, ProQR And Bluebird Report Positive Trial Results",2018-09-05 08:28:00-04:00,MASI,positive
801802.0,"Masimo Announces New Study Comparing Two Methods of Guiding Goal-Directed Fluid Therapy, Noninvasive Masimo PVi and Invasive Esophageal Doppler",2018-09-05 03:46:00-04:00,MASI,neutral
801803.0,"Stocks Which Set New 52-Week High Friday, August 31",2018-09-04 10:29:00-04:00,MASI,neutral
801804.0,"Stocks Which Set New 52-Week High Yesterday, August 29th",2018-08-30 11:47:00-04:00,MASI,neutral
801805.0,"Stocks Which Set New 52-Week High Friday, August 24th",2018-08-27 09:24:00-04:00,MASI,neutral
801806.0,"Stocks Which Set New 52-Week High Yesterday, August 23rd",2018-08-24 09:11:00-04:00,MASI,neutral
801807.0,"Stocks Which Set New 52-Week High Yesterday, August 22nd",2018-08-23 10:51:00-04:00,MASI,neutral
801808.0,"The Daily Biotech Pulse: Novartis Breast Cancer Trial Meets Endpoint, Medpace's Offering, Dexcom Buys TypeZero",2018-08-23 08:23:00-04:00,MASI,negative
801809.0,"Stocks Which Set New 52-Week High Yesterday, August 21st",2018-08-22 09:06:00-04:00,MASI,neutral
801810.0,"The Daily Biotech Pulse: FDA Snub For Allergan, Myriad's Q4 Beat, Mallinckrodt's Stannsoporfin",2018-08-22 08:20:00-04:00,MASI,negative
801811.0,"Stocks Which Set New 52-Week High Tues., Aug. 21, 2018",2018-08-21 14:50:00-04:00,MASI,neutral
801812.0,"The Daily Biotech Pulse: Merck's Keytruda Secures Approval For Expanded Label, ProPhase Labs Q2 Loss Narrows",2018-08-21 08:40:00-04:00,MASI,positive
801813.0,"Stocks Which Set New 52-Week High Yesterday, August 16th",2018-08-17 10:39:00-04:00,MASI,neutral
801814.0,"The Daily Biotech Pulse: Aveo Slips On Stock Offering, FDA Greenlights Generic EpiPen, Pfenex Exec Resigns",2018-08-17 08:15:00-04:00,MASI,negative
801815.0,"Stocks Which Set New 52-Week High Yesterday, August 14th",2018-08-15 12:29:00-04:00,MASI,neutral
801816.0,"The Daily Biotech Pulse: Vertex Awaits FDA Verdict, Strongbridge Falls On Offering, ReShape's Woes Continue",2018-08-15 08:48:00-04:00,MASI,negative
801817.0,New Study Investigates the Utility of Home Monitoring Using Masimo SET Pulse Oximetry to Screen Children with Down Syndrome for Risk of Obstructive Sleep Apnea Prior to Diagnostic Multichannel Sleep Studies,2018-08-13 03:44:00-04:00,MASI,negative
801818.0,"Stocks Which Set New 52-Week High Yesterday, August 9th",2018-08-10 10:03:00-04:00,MASI,neutral
801819.0,"Stocks Which Set New 52-Week High Yesterday, August 2nd",2018-08-03 11:16:00-04:00,MASI,neutral
801820.0,"The Daily Biotech Pulse: Zafgen Executive Departs; Adamas, Acceleron Accelerate On Earnings",2018-08-03 07:52:00-04:00,MASI,neutral
801821.0,Masimo Raises FY18 Adj. EPS Outlook From $2.88 To $2.90 vs $2.89 Est.,2018-08-01 17:21:00-04:00,MASI,neutral
801822.0,Masimo Raises FY18 Sales Outlook From $846M-$850M vs $848.32M Est.,2018-08-01 17:20:00-04:00,MASI,neutral
801823.0,"Masimo Q2 Adj. EPS $0.73 Beats $0.71 Estimate, Sales $211.6M Beat $207.85M Estimate",2018-08-01 17:18:00-04:00,MASI,neutral
801824.0,Stocks Which Set New 52-Week Highs Friday,2018-07-23 11:08:00-04:00,MASI,neutral
801825.0,Stocks Which Set New 52-Week High Yesterday,2018-07-20 09:05:00-04:00,MASI,neutral
801826.0,New Study Investigates the Utility of Masimo PVi as Part of Goal-Directed Fluid Management in Patients Undergoing Colorectal Surgery,2018-07-16 03:25:00-04:00,MASI,neutral
801827.0,Masimo Announces New Study Investigates Utility of Continuous Noninvasive Hemoglobin Measurement With SpHb for Reflecting Real-time Iatrogenic Hemodilution During Incremental Fluid Administration,2018-06-04 04:11:00-04:00,MASI,neutral
801828.0,"Benzinga's Daily Biotech Pulse: Clinical Hold For Crispr, Gilead Study Meets Endpoint, Akers Gets Grace Time",2018-05-31 08:22:00-04:00,MASI,positive
801829.0,"Proctor & Gamble, Mylan And More Stocks Sending Strong Signals This Week",2018-05-14 14:34:00-04:00,MASI,positive
801830.0,Masimo Announces New Study Investigates the Economic Impact and Utility of Continuous Noninvasive Hemoglobin Measurement with Masimo SpHb in Reducing Unnecessary Blood Transfusions,2018-05-14 03:41:00-04:00,MASI,neutral
801831.0,Masimo Raises FY2018 EPS Guidance from $2.80 to $2.88 vs $2.81 Est; Raises FY2018 Sales Guidance from $836.0M to $846.0M vs $838.80M Est,2018-05-02 16:27:00-04:00,MASI,neutral
801832.0,"Masimo Q1 EPS $0.75 Beats $0.69 Estimate, Sales $213M Beat $205.88M Estimate",2018-05-02 16:27:00-04:00,MASI,neutral
801833.0,Masimo Announces CE Marking of Rad-97 Pulse CO-Oximeter with Integrated NomoLine™ Capnography,2018-04-10 08:05:00-04:00,MASI,neutral
801834.0,Masimo  Announces New Study Shows Positive Results for Masimo SpHb During Acute Bleeding and After Fluid Resuscitation,2018-03-12 03:55:00-04:00,MASI,positive
801835.0,"Barclays Initiates Coverage On Masimo with Overweight Rating, Announces $97.00 Price Target",2018-03-09 06:58:00-05:00,MASI,negative
801836.0,"Masimo Sees 2018 EPS $2.80 vs. $2.65 Est., Sales $836M vs. $831.3M Est.",2018-02-27 16:27:00-05:00,MASI,neutral
801837.0,"Masimo Reports Q4 EPS $0.72 vs. $0.61 Est., Sales $225.2M vs. $201.39M Est.",2018-02-27 16:26:00-05:00,MASI,neutral
801838.0,Masimo Annonuces New Study Evaluates the Performance of Masimo PVi as a Predictor of Fluid Responsiveness in Mechanically Ventilated ICU Patients BW,2018-02-12 03:34:00-05:00,MASI,neutral
801839.0,Masimo Announces CE Mark for Eve CCHD Newborn Screening Application for the Rad-97 Pulse CO-Oximeter,2018-02-07 04:19:00-05:00,MASI,neutral
801840.0,Masimo Announces FDA Clearance of Next Generation SedLine Brain Function Monitoring,2018-01-29 08:03:00-05:00,MASI,neutral
801841.0,"Massimo Announced New Study Investigates the Clinical Utility of ORi, Masimo Oxygen Reserve Index, in Obese Patients",2018-01-22 03:56:00-05:00,MASI,neutral
801842.0,Masimo Announces FDA Clearance for Home Use of Rad-97,2018-01-09 08:04:00-05:00,MASI,neutral
801843.0,"Masimo Announces CE Mark, Release of Oxygen Reserve Index Rainbow Lite Sensors",2018-01-02 03:58:00-05:00,MASI,neutral
801844.0,Artemis Hospital Becomes First in India to Adopt Masimo Patient SafetyNet Across All Hospital Care Areas,2017-12-01 04:10:00-05:00,MASI,positive
801845.0,Masimo Announces FDA Clearance and Worldwide Release of NomoLine Capnography Sampling Lines,2017-11-27 08:01:00-05:00,MASI,neutral
801846.0,"Stifel 2017 Healthcare Conference Begins Today, Presenters Include: Seres Therapeutics, Verastem, TherapeuticsMD, Aerie Pharmaceuticals, Mednax, Celgene, TransEnterix, Exelixis, Tandem Diabetes Care and Masimo",2017-11-14 09:36:00-05:00,MASI,positive
801847.0,Masimo Raises FY17 Outlook: Sales From ~$769M To ~$774M vs $769.5M Est.,2017-10-31 16:06:00-04:00,MASI,neutral
801848.0,"Masimo Reports Q3 EPS $0.70 vs $0.52 In Same Qtr. Last  Year, Sales $193.7M vs $188.6M Est.",2017-10-31 16:06:00-04:00,MASI,neutral
801849.0,San Diego Bankruptcy Court Rules Sotera Wireless Employees Misappropriated Trade Secrets,2017-10-16 16:20:00-04:00,MASI,neutral
801850.0,Masimo Announces FDA Clearance and Full Market Release of Rad-97 Pulse CO-Oximeter,2017-09-18 08:02:00-04:00,MASI,neutral
801851.0,Masimo Announces Study Evaluates Performance of iSpO2 Rx Smart Device-Paired Pulse Oximeter in Screening Newborns for Critical Congenital Heart Disease,2017-09-05 04:06:00-04:00,MASI,positive
801852.0,Study Evaluates Utility of Masimo SpHb During High-Blood-Loss Oncosurgery,2017-08-28 04:24:00-04:00,MASI,neutral
801853.0,Masimo Announces Positive Results in Study of Masimo PVI as Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery,2017-08-21 04:00:00-04:00,MASI,positive
801854.0,"Benzinga's Top Upgrades, Downgrades For August 14, 2017",2017-08-14 09:25:00-04:00,MASI,positive
801855.0,BTIG Research Upgrades Masimo to Buy,2017-08-14 06:56:00-04:00,MASI,neutral
801856.0,Dubai Health Authority Implements Masimo Patient SafetyNet at Two Hospitals,2017-08-14 04:22:00-04:00,MASI,positive
801857.0,"Lightning Round: Jim Cramer Gives His Opinion On Blue Apron, Philip Morris And More",2017-08-08 06:57:00-04:00,MASI,neutral
801858.0,"Masimo Raises Guidance, Raises FY17 EPS From $2.65 to $2.80 vs $2.66 Est., Sales From $727M to $$736M vs $759.38M Est.",2017-08-02 16:18:00-04:00,MASI,neutral
801859.0,"Masimo Reports Q2 EPS $0.83 vs $0.71 Est., Sales $192.9M vs $189.03M Est.",2017-08-02 16:16:00-04:00,MASI,neutral
801860.0,"Stifel Nicolaus Initiates Coverage On Masimo with Buy Rating, Announces $105.00 Price Target",2017-07-11 06:12:00-04:00,MASI,neutral
801862.0,"Masimo Announces New Study Investigates the Clinical Utility of ORi, Masimo Oxygen Reserve Index",2017-06-12 04:13:00-04:00,MASI,neutral
801863.0,"8-K from Masimo Shows Co. Received FDA Warning Letter Related to Compliance with Current Good Manufacturing Practices at Co.'s Irvine, California Manufacturing Facility",2017-06-06 06:19:00-04:00,MASI,positive
801864.0,Masimo Announces FDA 510(k) Clearance of O3 Regional Oximetry for Pediatric Patients,2017-05-30 08:04:00-04:00,MASI,neutral
801865.0,"Midmark, Masimo Report Partnership to Improve Vital Signs Purchase",2017-05-15 08:03:00-04:00,MASI,positive
801866.0,"Masimo Sees FY17 Sales ~$759M vs $753M Est., EPS ~$2.65 vs $2.33 Est.",2017-05-03 16:09:00-04:00,MASI,neutral
801867.0,"Masimo Reports Q1 Adj. EPS $0.57 vs $0.60 Est., Sales $186.3M vs $184M Est.",2017-05-03 16:08:00-04:00,MASI,neutral
801868.0,Masimo Reports CE Marking of Rad-97 Pulse CO-Oximeter and Connectivity Hub with Noninvasive Blood Pressure,2017-03-20 08:06:00-04:00,MASI,negative
801869.0,18 Biggest Mid-Day Losers For Thursday,2017-03-16 13:10:00-04:00,MASI,negative
801870.0,"Benzinga's Top Upgrades, Downgrades For March 16, 2017",2017-03-16 09:30:00-04:00,MASI,positive
801871.0,PiperJaffray Downgrades Masimo To Neutral,2017-03-16 07:18:00-04:00,MASI,neutral
801872.0,How A Stock Gets Added To The S&P 500,2017-03-14 16:29:00-04:00,MASI,neutral
801873.0,Masimo Reports CE Marking of Respiration Rate Measurement on MightySat Rx,2017-02-15 08:04:00-05:00,MASI,neutral
801874.0,"Masimo Reports Q4 EPS Adj EPS $0.54 vs $0.52 Est, Sales $183.2M vs $180.48M Est.",2017-02-14 16:42:00-05:00,MASI,neutral
801875.0,"Earnings Scheduled For February 14, 2017",2017-02-14 04:49:00-05:00,MASI,neutral
801876.0,"Benzinga's Top Upgrades, Downgrades For February 13, 2017",2017-02-13 09:38:00-05:00,MASI,positive
801877.0,Raymond James Downgrades Masimo To Market Perform,2017-02-13 06:18:00-05:00,MASI,neutral
801878.0,Masimo Announces Launch of Advanced Monitoring Technologies Made for India,2017-01-02 09:46:00-05:00,MASI,positive
801879.0,Masimo Announces FDA 510(k) Clearance for TFA-1 Single-Patient-Use Forehead Sensor,2016-12-19 08:03:00-05:00,MASI,neutral
801880.0,"UPDATE: Masimo Shares Spike Higher as $65.50 Level Seems to Hold as Support Level, Up ~$0.75 Over Last Min",2016-12-16 12:03:00-05:00,MASI,positive
801881.0,Masimo Spikes to High of $66.49 on Volume,2016-12-16 12:03:00-05:00,MASI,neutral
801882.0,Masimo Receives Gates Foundation Grant For $4.95M to Develop Combined Pneumonia-Screening Device for High-Burden Settings,2016-11-11 08:03:00-05:00,MASI,positive
801883.0,"Knobbe Martens' Client Masimo Enters Multi-Year Business Partnership Agreement with Philips, Ending Longstanding Patent Litigation",2016-11-10 08:01:00-05:00,MASI,positive
801884.0,"Masimo Shares Ticking to Fresh Session Highs as Hearing Wedbush Issued Positive Mid-Day Comments on Co. Following Deal with Philips, Sees as 'Positive,' Raises Target to $67",2016-11-07 11:58:00-05:00,MASI,positive
801885.0,"UPDATE: Masimo Now Expects FY 2016 GAAP Earnings/Diluted Share, Exclusive of Impact of Business Partnership Agreement, To be $2.14 vs $2.13",2016-11-07 04:08:00-05:00,MASI,positive
801886.0,"Philips, Masimo Announce Multi-Year Business Partnership Agreement; Philips Agreed to Make $30M Cash Payment to Masimo in Q4 of 2016",2016-11-07 04:06:00-05:00,MASI,positive
801887.0,"UPDATE: Masimo Raises FY16 Sales Outlook from $689M to $692M vs $687.6M Est., GAAP EPS from $2.01 to $2.13 vs $2.02 Est.",2016-11-02 16:27:00-04:00,MASI,neutral
801888.0,Masimo Raises Outlook,2016-11-02 16:26:00-04:00,MASI,neutral
801889.0,"Masimo Reports Q3 GAAP EPS $0.52 vs $0.42 Est., Sales $167.6M vs $165.5M Est.",2016-11-02 16:25:00-04:00,MASI,neutral
801890.0,"25 Stocks Which Rallied Four Days, Then Sold Off On Friday",2016-10-24 06:24:00-04:00,MASI,neutral
801891.0,Masimo Reports New Study Showed Masimo SpHb May Reduce Excessive Intraoperative Red Blood Cell Transfusion,2016-09-09 08:04:00-04:00,MASI,neutral
801892.0,Masimo Announces Special Program For its Total Hemoglobin Program In Zika Affected Areas,2016-08-29 08:06:00-04:00,MASI,positive
801893.0,Masimo Reports CE Marking for RAS-45 Sensor for rainbow Acoustic Monitoring of Respiration Rate,2016-08-18 08:04:00-04:00,MASI,neutral
801894.0,"Masimo Sees FY16 Rev. ~$689M vs. Est. $678M, EPS $2.01 vs. Est. $1.83",2016-08-03 17:20:00-04:00,MASI,neutral
801895.0,"Masimo Reports Q2 EPS $0.57 vs. Est. $0.41, Rev. $172.6M vs. Est. $166M",2016-08-03 17:19:00-04:00,MASI,neutral
801896.0,Masimo Reports Evaluation of Co.'s PVI as a Predictor of Fluid Responsiveness in Patients Undergoing Liver Transplantation,2016-07-21 08:04:00-04:00,MASI,neutral
801897.0,Masimo Reports FDA 510(k) Clearance for Radius-7 with rainbow Technology,2016-06-28 08:03:00-04:00,MASI,neutral
801898.0,"Amid Wage Disparities And Political Concerns Over Jobs, Top CEOs Bring In Beaucoup Incomes",2016-05-19 11:34:00-04:00,MASI,positive
801899.0,Benzinga's Volume Movers,2016-05-05 10:36:00-04:00,MASI,neutral
801900.0,Stocks Hitting 52-Week Highs,2016-05-05 10:01:00-04:00,MASI,neutral
801901.0,Benzinga's Top Upgrades,2016-05-05 08:51:00-04:00,MASI,positive
801902.0,Piper Jaffray Upgrades Masimo to Overweight,2016-05-05 06:31:00-04:00,MASI,negative
801903.0,Masimo Offers New Study on Accuracy of Blue Sensors at Saturations Below 85% in Children with Cyanotic Congenital Heart Disease,2016-03-17 08:04:00-04:00,MASI,neutral
801904.0,"Masimo Sees FY16 Sales ~$670M vs $666.2M Est., Adj. EPS ~$1.74 vs $1.67 Est.",2016-02-23 16:40:00-05:00,MASI,neutral
801905.0,"Masimo Reports Q4 Adj. EPS $0.15, GAAP EPS $0.46 vs $0.39 Est., Sales $167.3M vs $164.3M Est.",2016-02-23 16:40:00-05:00,MASI,neutral
801906.0,Masimo Announces FDA 510 Clearance for Root with Noninvasive Blood Pressure and Temperature,2016-02-17 08:05:00-05:00,MASI,negative
801907.0,Raymond James Downgrades Masimo to Outperform,2016-01-06 07:45:00-05:00,MASI,neutral
801908.0,In New Study EMMA™ Capnograph Has Comparable Accuracy to Sidestream Capnography Against Gold-Standard Blood Gas Analysis,2015-11-12 08:17:00-05:00,MASI,neutral
801909.0,"Masimo Reports Q3 Adj. EPS $0.40 vs $0.31 Est., Sales $152.6M vs $149.3M Est.; Sees FY15 Sales ~$627M vs $622M Est., GAAP EPS ~$1.49 vs $1.43 ESst.",2015-11-05 18:50:00-05:00,MASI,neutral
801910.0,"Masimo Reports Q3 Adj. EPS $0.40 vs $0.31 Est., Sales $152.6M vs $149.3M Est.; Sees FY15 Sales ~$627M vs $622M Est., GAAP EPS ~$1.49 vs $1.43 ESst.",2015-11-05 18:49:00-05:00,MASI,neutral
801911.0,"Masimo Reports Q3 Adj. EPS $0.40 vs $0.31 Est., Sales $152.6M vs $149.3M Est.; Sees FY15 Sales ~$627M vs $622M Est., GAAP EPS ~$1.49 vs $1.43 ESst.",2015-11-05 18:46:00-05:00,MASI,neutral
801912.0,"Masimo Reports Q3 Adj. EPS $0.40 vs $0.31 Est., Sales $152.6M vs $149.3M Est.; Sees FY15 Sales ~$627M vs $622M Est., GAAP EPS ~$1.49 vs $1.43 ESst.",2015-11-05 18:43:00-05:00,MASI,neutral
801913.0,"Masimo Reports Q3 Adj. EPS $0.40 vs $0.31 Est., Sales $152.6M vs $149.3M Est.; Sees FY15 Sales ~$627M vs $622M Est., GAAP EPS ~$1.49 vs $1.43 ESst.",2015-11-05 18:42:00-05:00,MASI,neutral
801914.0,"Masimo Reports Q3 Adj. EPS $0.40 vs $0.31 Est., Sales $152.6M vs $149.3M Est.; Sees FY15 Sales ~$627M vs $622M Est., GAAP EPS ~$1.49 vs $1.43 ESst.",2015-11-05 18:39:00-05:00,MASI,neutral
801915.0,Masimo Announces FDA 510(k) Clearance for MightySat Rx Fingertip Pulse Oximeter,2015-10-27 08:05:00-04:00,MASI,neutral
801916.0,Masimo PVI® Evaluated in 18-Study Meta-Analysis for Ability to Help Clinicians Assess Fluid Responsiveness,2015-10-08 08:06:00-04:00,MASI,positive
801917.0,15 Stocks Moving In Friday's After-Hours Trading,2015-09-25 17:11:00-04:00,MASI,neutral
801918.0,Brazil's A.C.Camargo Cancer Center Adopts Masimo SpHb for Noninvasive and Continuous Hemoglobin Monitoring,2015-08-25 04:25:00-04:00,MASI,negative
801919.0,"Masimo Corp Reports Q2 EPS $0.36 Vs Est $0.32, Sales $155.7M vs Est $149.94M; Raise FY 2015 Adj EPS To $1.61 Vs Est $1.36 & Revs Raised To $621M Vs Est $652.67M",2015-08-04 17:11:00-04:00,MASI,neutral
801920.0,Benzinga's Volume Movers,2015-07-21 10:27:00-04:00,MASI,neutral
801921.0,"Masimo Reports Prelim. Q2 Product Sales $147M-$147M, Total Sales $155M-$156M vs $148M Est., GAAP EPS $0.35-$0.36",2015-07-21 09:01:00-04:00,MASI,neutral
801922.0,BTIG Research Downgrades Masimo to Neutral,2015-07-16 07:43:00-04:00,MASI,neutral
801923.0,"Masimo Reports Root CE Marking with Blood Pressure, Temperature",2015-06-15 08:05:00-04:00,MASI,negative
801924.0,Raymond James Upgrades Masimo To  Strong Buy,2015-06-12 10:24:00-04:00,MASI,positive
801925.0,Stocks Hitting 52-Week Highs,2015-06-12 10:20:00-04:00,MASI,neutral
801926.0,Benzinga's Top Upgrades,2015-06-12 08:52:00-04:00,MASI,positive
801927.0,Raymond James Upgrades Masimo to Strong Buy,2015-06-12 07:35:00-04:00,MASI,positive
801928.0,Masimo $467M Award For Patent Infringement By Phillips  Upheld By District Court,2015-05-19 08:04:00-04:00,MASI,positive
801929.0,"Perioperative Increased Recovery Program That Included Masimo PVI Led to Significant Reductions in Length of Stay, Complications and Costs",2015-05-14 08:02:00-04:00,MASI,positive
801930.0,"Masimo Reports Q1 Adj. EPS $0.41 vs $0.35 Est., Sales $154.5M vs $151M Est.; Raises FY Outlook",2015-05-06 16:39:00-04:00,MASI,neutral
801931.0,Top 4 Small-Cap Stocks In The Medical Appliances & Equipment Industry With The Highest ROA,2015-04-22 04:45:00-04:00,MASI,positive
801932.0,"Masimo Reports Q4 EPS $0.40 vs $0.37 Est., Sales $161.8M vs $159.5M Est.",2015-02-17 16:09:00-05:00,MASI,neutral
801933.0,"Masimo Announces FDA 510(k) Clearance of Radius-7(TM) -- First rainbow(R) SET(R) Noninvasive Wearable, Wireless Monitor for Root(R)",2014-12-01 13:22:00-05:00,MASI,neutral
801934.0,"13G Filing from Camber Capital Mgmt on Masimo Shows 5.44% Stake, Had Shown 3.47% Stake as of Jun. 30th",2014-11-10 12:47:00-05:00,MASI,neutral
801935.0,New Clinical Study Shows Accuracy of Masimo Noninvasive Spot-Check Hemoglobin (SpHb(R)) in Trauma Patients ,2014-11-05 08:19:00-05:00,MASI,negative
801936.0,Masimo Corporation Reports Q3 EPS of $0.27 vs $0.25 Est; Revenue of $137.10M vs $144.19M Est,2014-10-29 16:18:00-04:00,MASI,neutral
801937.0,"Arkansas Heart Hospital Upgrades to Masimo SET(R) Pulse Oximetry, Resulting in Significant Reduction in False Alarms and Improved Patient Care and Satisfaction ",2014-10-23 08:14:00-04:00,MASI,positive
801938.0,Two New Clinical Studies Show Masimo Noninvasive Hemoglobin Demonstrated Similar Precision As Hemoglobin From Point Of Care Devices ,2014-10-16 08:13:00-04:00,MASI,positive
801939.0,"Retrospective Study Of Enhanced Recovery After Surgery Program For Patients Undergoing Colorectal Surgery, Which Included Fluid Therapy Tailored to Masimo's PVI, Showed Reduced Length Of Stay and Cost Savings ",2014-10-14 08:07:00-04:00,MASI,neutral
801940.0,Masimo Announces CE Mark of Eve(TM) Newborn Screening Application for Radical-7 ,2014-10-10 08:08:00-04:00,MASI,neutral
801941.0,Masimo Wins $466M Verdict In Philips Patent Trial,2014-10-01 15:40:00-04:00,MASI,positive
801942.0,Masimo Spikes Higher,2014-10-01 15:33:00-04:00,MASI,neutral
801943.0,Masimo Unveils MX-5 OEM Circuit Board,2014-09-25 14:45:00-04:00,MASI,neutral
801944.0,"8-K from Masimo Shows FDA Warning Letter Related to Irvine, CA Facility",2014-08-15 07:40:00-04:00,MASI,negative
801945.0,Piper Jaffray Downgrades Masimo Corporation to Neutral,2014-08-08 06:49:00-04:00,MASI,neutral
801946.0,Masimo Corporation Reports Q2 EPS of $0.27 vs $0.29 Est,2014-08-07 16:06:00-04:00,MASI,neutral
801947.0,"UPDATE: BTIG Initiates Coverage On Masimo, Sees 31% Premium To Shares",2014-07-08 12:36:00-04:00,MASI,positive
801948.0,"BTIG Research Initiates Coverage on Masimo Corporation at Buy, Announces $32.00 PT",2014-07-08 06:36:00-04:00,MASI,neutral
801949.0,"Masimo Announces FDA Clearance of Root Patient Monitoring Platform With Capnography, IRIS Standalone Device Connectivity, And MOC-9 Third-Party Measurement Expansion ",2014-06-30 08:07:00-04:00,MASI,neutral
801950.0,"UPDATE: Live Nation, Arris Group Will Replace Masimo, Brink's in S&P MidCap 400",2014-06-12 17:20:00-04:00,MASI,neutral
801951.0,Masimo Announces CE Mark of iSp02(TM) Rx Pulse Oximeter for Mobile Devices,2014-05-29 07:58:00-04:00,MASI,neutral
801952.0,Masimo in Filing Says Received Grand Jury Subpoena from US Attorney's Office for Central District of California,2014-05-09 06:36:00-04:00,MASI,positive
801953.0,Masimo Corporation Sees FY2014 EPS $1.24-1.33; Sees Sales $588.0M-598.0M,2014-04-30 16:12:00-04:00,MASI,neutral
801954.0,Masimo Corporation Reports Q1 EPS of $0.30 vs $0.29 Est,2014-04-30 16:12:00-04:00,MASI,neutral
801955.0,Masimo Corporation Sees FY2014 EPS $1.13-1.28; Sees Sales $578.0M-598.0M vs $581.60M Est,2014-02-13 16:24:00-05:00,MASI,neutral
801956.0,"Masimo Corporation Reports Q4 EPS of $0.31, Inline; Revenue of $142.40M vs $145.25M Est",2014-02-13 16:19:00-05:00,MASI,neutral
801957.0,Masimo Announces CE Marking of O3(TM) Regional Oximetry,2014-01-23 08:04:00-05:00,MASI,neutral
801958.0,Form 8-K from Masimo Corp. Shows Expecting $5.39M Charge in Q4 Related to Award Made to Plaintiff,2014-01-22 17:33:00-05:00,MASI,positive
801959.0,UPDATE: BMO Capital Markets Reiterates on Masimo Following Mixed 3Q13 Results,2013-10-31 11:25:00-04:00,MASI,neutral
801960.0,Masimo Corporation Raises FY2013 GAAP EPS Guidance from $1.14 to $1.16,2013-10-30 16:28:00-04:00,MASI,neutral
801961.0,Masimo Corporation Reports Q3 EPS of $0.27; Revenue of $131.40M,2013-10-30 16:27:00-04:00,MASI,neutral
801962.0,Masimo Corporation Reports Q2 EPS of $0.30 vs $0.28 Est; Revenue of $137.40M vs $136.36M Est,2013-07-31 16:40:00-04:00,MASI,neutral
801963.0,UPDATE: Wedbush Initiates Masimo at Outperform on Recurring Revenue Stream,2013-07-16 08:27:00-04:00,MASI,neutral
801964.0,"Wedbush Initiates Coverage on Masimo Corporation at Outperform, Announces $28.00 PT",2013-07-16 07:27:00-04:00,MASI,neutral
801965.0,Masimo Signs Far-Reaching Pulse Oximetry Distribution Deal with Butler Schein Animal Health,2013-06-11 08:06:00-04:00,MASI,neutral
801966.0,Citigroup Upgrades Masimo Corporation to Neutral,2013-05-03 09:41:00-04:00,MASI,neutral
801967.0,"Masimo Corporation Reports Q1 EPS of $0.28, Inline; Revenue of $135.90M vs $134.46M Est",2013-05-02 16:12:00-04:00,MASI,neutral
801968.0,"Janney Capital Initiates Coverage on Masimo Corporation at Buy, Announces $26.00 PT",2013-04-09 16:41:00-04:00,MASI,neutral
801969.0,"BMO Capital Maintains Market Perform on Masimo Corporation, Lowers PT to $22.00",2013-02-15 08:00:00-05:00,MASI,negative
801970.0,Masimo Announces Adoption of Stock Repurchase Program,2013-02-14 16:10:00-05:00,MASI,neutral
801971.0,Masimo Corporation Sees FY2013 EPS $1.14 vs $1.21 Est; Sees Sales $548.0M vs $541.0M Est,2013-02-14 16:07:00-05:00,MASI,neutral
801972.0,Masimo Announces 6M BUyback Plan,2013-02-14 16:07:00-05:00,MASI,neutral
801973.0,Masimo Corporation Reports Q4 EPS of $0.26 vs $0.29 Est; Revenue of $132.20M,2013-02-14 16:07:00-05:00,MASI,neutral
801974.0,"Masimo Says New Study Shows Noninvasive, Continuous Total Hemoglobin Monitoring Significantly Reduces Blood Transfusions in High Blood Loss Surgery",2013-01-10 12:04:00-05:00,MASI,negative
801975.0,"Mindray Offers Statement on Masimo Suit, Says Will 'Vigorously Defend the Actions'",2013-01-07 08:08:00-05:00,MASI,positive
801976.0,Masimooration Reports Q3 EPS $0.26 vs $0.25 Est; Revenues $119.1M vs $121.01M Est,2012-11-01 16:34:00-04:00,MASI,neutral
801977.0,"Citigroup Maintains Masimooration at Sell, Raises PT from $19 to $20",2012-09-24 06:43:00-04:00,MASI,neutral
801978.0,"Citigroup Maintains Masimooration at Sell, Raises PT from $19 to $20",2012-09-21 15:55:00-04:00,MASI,neutral
801979.0,Top 4 Small-Cap Stocks In The Medical Appliances & Equipment Industry With The Highest Operating Margin,2012-08-15 04:44:00-04:00,MASI,positive
801980.0,Masimooration Reports Q2 EPS $0.30 vs $0.28 Est; Revenues $122.8M vs $120.53M Est,2012-08-01 16:18:00-04:00,MASI,neutral
801981.0,"Masimo Enters Noninvasive Multigas Monitoring, including Capnography, with Acquisition of PHASEIN ",2012-08-01 16:14:00-04:00,MASI,neutral
801982.0,Masimo Signs Pulse Oximetry Distribution Deal with MWI Veterinary Supply ,2012-07-23 09:02:00-04:00,MASI,neutral
801983.0,New Study Affirms Masimo rainbow® Pulse CO-Oximetry™ Accuracy for Noninvasive Carboxyhemoglobin and Methemoglobin Measurements ,2012-07-09 09:03:00-04:00,MASI,neutral
801984.0,New Study Affirms Masimo Rainbow Pulse CO-Oximetry Accuracy for Noninvasive Carboxyhemoglobin and Methemoglobin Measurements,2012-07-09 09:02:00-04:00,MASI,neutral
801985.0,Masimo Signs Pronto-7 Distribution Deal with PSS World Medical ,2012-07-02 09:03:00-04:00,MASI,neutral
801986.0,ThinkEquity Initiates Coverage On Masimooration at Buy,2012-06-22 08:47:00-04:00,MASI,neutral
801987.0,Premier Healthcare Renews Supplier Agreement with Masimo ,2012-06-04 09:03:00-04:00,MASI,positive
801988.0,First Published Study on Masimo Acoustic Respiration Rate Demonstrates Significantly Higher Patient Tolerance and Similar Accuracy Compared to Capnometry in Post-Surgical Patients ,2012-05-17 09:04:00-04:00,MASI,positive
801989.0,Novation Inks Supplier Contract Category Agreement for Masimo SET pulse oximetry and rainbow SET Pulse CO-Oximetry™ ,2012-05-03 09:56:00-04:00,MASI,positive
801990.0,Masimo Reports Q1 EPS $0.27 vs $0.27 Est; Revenues $119.2M vs $118.09M Est,2012-05-02 16:34:00-04:00,MASI,neutral
801991.0,Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors ,2012-04-25 09:01:00-04:00,MASI,neutral
801992.0,Essential Medical Dismisses Patent Case against Masimo and Cercacor  ,2012-04-23 09:04:00-04:00,MASI,neutral
801993.0,Masimo Pronto-7™ Receives China and South Korea Regulatory Clearances ,2012-04-12 09:17:00-04:00,MASI,neutral
801994.0,"Feltl and Company Maintains Masimooration at Hold, Raises PT from $23.5 to $24.5",2012-03-12 12:40:00-04:00,MASI,neutral
801995.0,GE Healthcare Partners With Masimo to Incorporate rainbow SET Technology With GE Patient Monitors  ,2012-02-23 08:07:00-05:00,MASI,neutral
801996.0,Feltl & Company Reiterates Hold on Masimo Corporation,2012-02-15 10:35:00-05:00,MASI,neutral
801997.0,Collins Stewart: Masimo's '11 Ends Well and '12 Guidance May Prove Conservative,2012-02-15 09:14:00-05:00,MASI,positive
801998.0,Bank of America: Masimo's Numbers Still at Risk,2012-02-15 08:55:00-05:00,MASI,negative
801999.0,UPDATE: Brean Murray Carret Raises Target to $26 on Masimo Corporation,2012-02-15 08:47:00-05:00,MASI,neutral
802000.0,"Brean Murray Carret & Co. Maintains Masimooration at Buy, Raises PT from $24 to $26",2012-02-15 06:42:00-05:00,MASI,neutral
802001.0,Masimo Corporation Reports Q4 Prelim EPS $0.23 vs $0.23 Est; Revenues $112.3M vs $110.34M Est	 		,2012-02-14 16:01:00-05:00,MASI,neutral
802002.0,Brean Murray Carret: Upside Looks Likely for Masimo's 4Q,2012-02-14 08:48:00-05:00,MASI,negative
802003.0,UPDATE: Citigroup Downgrades Masimo Corporation to Sell,2012-02-10 12:10:00-05:00,MASI,neutral
802004.0,"Citigroup Downgrades Masimooration from Neutral to Sell, Lowers PT from $21 to $20",2012-02-10 06:21:00-05:00,MASI,negative
802005.0,"Morgan Keegan Maintains Outperform, $26 Target on Masimo Corporation",2012-01-17 08:05:00-05:00,MASI,neutral
802006.0,"UPDATE: Brean Murray Carret Maintains Buy, Lowers PT to $24 on Masimo Corporation",2012-01-13 10:32:00-05:00,MASI,negative
802007.0,Masimo Announces FDA Clearance and Full Market Release of the New Pronto-7 for Noninvasive Total Hemoglobin Spot-Check Measurement,2012-01-09 12:24:00-05:00,MASI,neutral
802008.0,New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology  ,2011-12-13 08:03:00-05:00,MASI,neutral
802009.0,"PiperJaffray Reiterates Overweight, $31 PT On Masimo",2011-11-29 12:37:00-05:00,MASI,negative
802010.0,Bank of America Initiates Coverage on Masimo With an Underperform Rating,2011-11-18 07:17:00-05:00,MASI,neutral
802011.0,"Bank of America Initiates Masimo at Underperform, $19 PO",2011-11-18 06:04:00-05:00,MASI,negative
802012.0,UPDATE: Morgan Keegan Lowers PT to $27 on Masimo ,2011-10-26 09:35:00-04:00,MASI,negative
802013.0,Morgan Keegan Lowers PT on Masimo to $27,2011-10-26 08:12:00-04:00,MASI,negative
802014.0,Piper Jaffray Maintains Overweight Rating on Masimo,2011-10-26 07:45:00-04:00,MASI,negative
802015.0,Piper Jaffray Lowers PT on Masimo Corporation to $31,2011-10-26 06:37:00-04:00,MASI,negative
802016.0,"Masimo Sees FY11 EPS $1.04-$1.06, Had Seen $1.17-$1.25; Rev $436M-$439M, Had Seen $446M-$463M",2011-10-25 16:16:00-04:00,MASI,neutral
802017.0,PREVIEW: Masimo Corp to Resume Trading at 4:35pm,2011-10-25 16:14:00-04:00,MASI,neutral
802018.0,Masimo Corp Reports Q3 EPS $0.24 vs $0.27 Est; Revenues $104M vs $109.67M Est			,2011-10-25 16:14:00-04:00,MASI,neutral
802019.0,Masimo Halted; Pending News,2011-10-25 16:02:00-04:00,MASI,neutral
802020.0,Guangdong Biolight Meditech Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology ,2011-10-24 13:09:00-04:00,MASI,neutral
802021.0,Piper Jaffray Maintains Overweight on Masimo,2011-10-17 09:09:00-04:00,MASI,negative
802022.0,Masimo Launches the 2011 Radical-7 with rainbow® Acoustic Monitoring and In Vivo Adjustment,2011-10-13 16:24:00-04:00,MASI,neutral
802023.0,Masimo rainbow Acoustic Monitoring Technology Cleared for Market in Japan ,2011-10-10 11:00:00-04:00,MASI,positive
802024.0,UPDATE: Piper Jaffray Lowering Price Target On Masimo ,2011-08-10 08:09:00-04:00,MASI,negative
802025.0,"UPDATE: Morgan Keegan Reiterates Outperform on Masimo, Slashes PT to $33",2011-08-10 07:37:00-04:00,MASI,negative
802026.0,Piper Jaffray Lowers PT On Masimo To $36,2011-08-10 06:15:00-04:00,MASI,negative
802027.0,Morgan Keegan Lowers PT On Masimo To $33,2011-08-10 06:03:00-04:00,MASI,negative
802028.0,Masimo Announces Adoption of Stock Repurchase Program of up to 3M Shares,2011-08-09 16:26:00-04:00,MASI,positive
802029.0,Masimo Reports Q2 EPS $0.28 vs $0.28 Est; Revenues $109.6M vs $111.27M Est		,2011-08-09 16:06:00-04:00,MASI,neutral
802030.0,Masimo Announces Rainbow Agreement with Philips ,2011-06-15 08:01:00-04:00,MASI,positive
802031.0,"Masimo Initiates Limited Market Release of E1, Single-Patient-Use Ear Sensor for Pulse Oximetry Monitoring  ",2011-06-02 13:47:00-04:00,MASI,negative
802032.0,Masimo Announces New Study Demonstrates the Accuracy of Noninvasive and Continuous Hemoglobin Monitoring in Patients in Surgery and Intensive Care,2011-05-16 14:10:00-04:00,MASI,positive
802033.0,Morgan Keegan Comments On Masimo Corporation Following Recent Earnings Release,2011-05-04 08:13:00-04:00,MASI,neutral
802034.0,Piper Jaffray Comments On Masimo 1Q11 Results,2011-05-04 07:31:00-04:00,MASI,neutral
802035.0,Masimo Corp Reports EPS of $0.30 vs. $0.30 Estimate; Revenues $113M vs. $110.7M Estimate (MASI),2011-05-03 16:01:00-04:00,MASI,neutral
802036.0,New Published Study Finds Masimo SET Delivers More Reliable Measurements Significantly Faster Than Other Pulse Oximetry Technologies ,2011-04-11 11:01:00-04:00,MASI,neutral
802037.0,"Benzinga's Top Downgrades (MASI, BKE, TGT, COST)",2011-04-08 08:10:00-04:00,MASI,positive
802038.0,"NASDAQ Stocks Hitting 52-Week Highs (MASI, RCII, CNTY, SEAC)",2011-04-07 10:06:00-04:00,MASI,neutral
802039.0,Piper Jaffray Reiterates Overweight on Masimo Corporation (MASI),2011-03-11 07:54:00-05:00,MASI,negative
802040.0,Masimo Reports Q4 EPS of $0.29 vs. $0.26,2011-02-15 16:01:00-05:00,MASI,neutral
802041.0,"Covidien Outshines, Backs View  - Analyst Blog",2011-02-02 12:31:00-05:00,MASI,negative
802042.0,"Covidien Outshines, Backs View  - Analyst Blog",2011-02-02 12:00:00-05:00,MASI,negative
802043.0,Study Finds Noninvasive Masimo PVI Accurately Predicts Fluid Responsiveness in Intensive Care Patients ,2011-02-01 14:54:00-05:00,MASI,positive
802044.0,"Benzinga's Volume Movers (MASI, CYOU, ASIA, OPLK)",2011-01-31 10:46:00-05:00,MASI,neutral
802045.0,"Masimo To Negotiate Lower Royalties From COV Post 1Q11, Bets Citigroup",2011-01-11 08:56:00-05:00,MASI,negative
802046.0,Options Brief: Masimo Corporation (MASI),2011-01-03 13:16:00-05:00,MASI,neutral
802047.0,Takeover Candidates In Medical Tech ,2010-12-20 14:31:00-05:00,MASI,neutral
802048.0,"Insiders Trading MOT, FSLR, AON, CMG",2010-12-02 08:00:00-05:00,MASI,neutral
802049.0,Masimo Declares Special Cash Dividend of $.75,2010-11-22 09:05:00-05:00,MASI,positive
802050.0,"Top 4 Stocks In The Medical Appliances & Equipment Industry With The Highest ROE (LZR, MASI, VAR, SNN)",2010-11-04 03:53:00-04:00,MASI,positive
802051.0,"Masimo Beats on EPS, Sales Miss - Analyst Blog",2010-11-03 10:33:00-04:00,MASI,negative
802052.0,Study Finds Clinical Practice Change with Masimo SET Pulse Oximetry Reduces Severe Eye Damage (MASI),2010-09-30 13:02:00-04:00,MASI,negative
802053.0,Masimo SpMet Test is Accurate - Analyst Blog,2010-09-23 10:54:00-04:00,MASI,neutral
802054.0,Masimo Gets SpHb Clearance in Japan - Analyst Blog,2010-09-16 11:42:00-04:00,MASI,neutral
802055.0,Piper Jaffray Sees 30% Rise In Shares Of Masimo (MASI),2010-09-16 08:15:00-04:00,MASI,positive
802056.0,William Blair Maintains Market Perform Rating On MASI,2010-08-04 09:19:00-04:00,MASI,neutral
802057.0,"Masimo (MASI) Immaterializes SEDline (HSP) Acquisition (MASI, HSP)",2010-07-14 13:56:00-04:00,MASI,neutral
802058.0,"Top 4 Stocks In The Medical Appliances And Equipment Industry With The Highest Profit Margin (ISRG, MDT, MASI, RMD)",2010-07-06 07:00:00-04:00,MASI,positive
802059.0,"Benzinga’s Volume Movers (SENO, AMMD, DGIT, TRS, MASI)",2010-05-05 14:56:00-04:00,MASI,neutral
802060.0,Reduce Your Risk In The Initial Public Offering Market With This IPO ETF,2010-03-25 19:56:00-04:00,MASI,negative
802061.0,"Medical Devices Industry Update (BAX, BCR, COO, MASI, HAE)",2010-03-23 12:33:00-04:00,MASI,neutral
802062.0,"Stock Watch-List for December 23, 2009",2009-12-23 10:56:00-05:00,MASI,neutral
